Notably, EIF3J-AS1 expression was significantly higher in IDH-mutant gliomas compared to wild-type gliomas across all grades (Fig. 1C) and was elevated in patients with 1p/19q co-deletion compared to those without (Fig. 1D). This evidence concerns the gene EIF3J and central nervous system cancer.